Company		Revenue (₹ Cr)			Profit (₹ Cr)		Per share		8Q profit
Symbol	Sector	Reported	YoY	QoQ	Reported	YoY	EPS	vs consensus	Trend
SUNPHARMA Sun Pharmaceutical Industries Ltd	Healthcare	16,199	up+11.9%	up+5.9%	1,995	down−36.2%	8.29	Miss −37.2% est. 13.22
AUROPHARMA Aurobindo Pharma Ltd	Healthcare	10,263	up+23.9%	up+12.2%	1,124	up+32.5%	—	No estimate
DRREDDY Dr Reddys Laboratories Ltd	Healthcare	8,698	down−1.5%	up+7.4%	913	down−31.7%	—	Beat +22.8% est. 9.04
ZYDUSLIFE Zydus Lifesciences Ltd	Healthcare	7,910	up+29.2%	down−1.3%	928	down−25.1%	—	No estimate
LUPIN Lupin Ltd	Healthcare	7,827	up+11.1%	down−5.4%	1,155	down−22.2%	—	No estimate
CIPLA Cipla Ltd	Healthcare	7,404	down−2.4%	up+4.0%	852	down−37.1%	—	Miss −6.2% est. 11.58
TORNTPHARM Torrent Pharmaceuticals Ltd	Healthcare	4,979	up+50.8%	up+1.2%	534	down−9.6%	14.04	Miss −13.0% est. 16.15
BIOCON Biocon Ltd	Healthcare	4,389	up+2.2%	up+1.2%	57	down−57.4%	—	No estimate
MANKIND Mankind Pharma Ltd	Healthcare	4,338	up+17.3%	up+7.6%	716	up+37.7%	—	Beat +7.9% est. 15.97
EMCURE Emcure Pharmaceuticals Ltd	Healthcare	2,820	up+24.2%	up+9.3%	325	up+29.5%	—	No estimate
PPLPHARMA Piramal Pharma Ltd	Healthcare	2,617	up+28.0%	up+15.3%	5	n/a	—	Beat +115.6% est. −0.26
APLLTD Alembic Pharmaceuticals Ltd	Healthcare	2,603	up+36.3%	up+21.1%	334	up+81.5%	—	No estimate
LAURUSLABS Laurus Labs Ltd	Healthcare	2,206	up+33.5%	up+8.9%	436	up+124.8%	—	Beat +24.0% est. 6.59
AJANTPHARM Ajanta Pharma Ltd	Healthcare	1,794	up+32.5%	up+10.3%	388	up+49.3%	—	Beat +29.7% est. 23.95
GRANULES Granules India Ltd	Healthcare	1,560	up+20.3%	up+5.6%	182	up+38.8%	—	No estimate
STAR Strides Pharma Science Ltd	Healthcare	1,430	up+17.1%	up+13.0%	134	up+1.6%	—	No estimate
AKUMS Akums Drugs & Pharmaceuticals Ltd	Healthcare	1,342	up+31.9%	up+15.0%	115	up+166.4%	—	No estimate
GLAXO Glaxosmithkline Pharmaceuticals Ltd	Healthcare	1,184	up+20.8%	up+26.2%	336	up+30.7%	—	No estimate
INDGN Indegene Ltd	Healthcare	1,122	up+39.6%	up+5.6%	112	up+10.1%	—	Miss −4.3% est. 4.88
WOCKPHARMA Wockhardt Ltd	Healthcare	969	up+23.9%	up+4.3%	73	down−11.0%	—	No estimate
MARKSANS Marksans Pharma Ltd	Healthcare	940	up+30.6%	up+11.8%	144	up+45.0%	—	No estimate
ERIS ERIS Lifesciences Ltd	Healthcare	892	up+12.7%	up+2.2%	187	up+39.7%	—	Beat +20.5% est. 11.00
SYNGENE Syngene International Ltd	Healthcare	833	down−8.6%	up+13.1%	32	down−52.0%	—	Miss −38.9% est. 1.31
AARTIDRUGS Aarti Drugs Ltd	Healthcare	826	up+26.5%	up+17.5%	83	up+83.9%	—	No estimate
IOLCP IOL Chemicals & Pharmaceuticals Ltd	Healthcare	795	up+40.0%	up+5.2%	65	up+116.9%	—	No estimate
MOREPENLAB Morepen Laboratories Ltd	Healthcare	747	up+81.2%	up+31.0%	89	up+116.8%	—	No estimate
PFIZER Pfizer Ltd	Healthcare	727	up+13.2%	up+11.3%	313	up+65.7%	—	Beat +52.0% est. 45.05
ALIVUS Alivus Life Sciences Ltd	Healthcare	682	up+16.0%	up+6.6%	197	up+51.3%	—	No estimate
UNICHEMLAB Unichem Laboratories Ltd	Healthcare	640	up+10.6%	up+1.1%	22	n/a	—	No estimate
AARTIPHARM Aarti Pharmalabs Ltd	Healthcare	610	up+46.0%	up+13.9%	71	up+155.3%	—	No estimate
ANTHEM Anthem Biosciences Ltd	Healthcare	594	up+8.0%	up+42.1%	211	up+22.2%	—	No estimate
FDC FDC Ltd	Healthcare	572	up+21.0%	down−14.4%	49	up+75.2%	—	No estimate
INDOCO Indoco Remedies Ltd	Healthcare	520	up+7.3%	up+11.1%	19	n/a	—	Beat +134.4% est. 0.90
SANOFI Sanofi India Ltd	Healthcare	492	up+3.5%	up+12.3%	117	up+53.6%	—	No estimate
NEULANDLAB Neuland Laboratories Ltd	Healthcare	450	down−12.5%	down−30.0%	52	down−46.8%	—	Beat +18.9% est. 33.84
CORONA Corona Remedies Ltd	Healthcare	441	up+22.2%	up+4.5%	60	up+16.0%	—	No estimate
ACUTAAS Acutaas Chemicals Ltd	Healthcare	437	up+42.8%	up+32.4%	123	up+71.0%	—	No estimate
HIKAL Hikal Ltd	Healthcare	434	up+36.3%	up+7.8%	−6	n/a	—	No estimate
SOLARA Solara Active Pharma Sciences Ltd	Healthcare	417	up+32.9%	up+9.3%	28	n/a	5.86	No estimate
PGHL Procter & Gamble Health Ltd	Healthcare	382	up+17.7%	up+5.1%	112	up+25.3%	—	No estimate
SMSPHARMA SMS Pharmaceuticals Ltd	Healthcare	316	up+30.6%	up+52.7%	40	up+59.4%	—	No estimate
BLISSGVS Bliss GVS Pharma Ltd	Healthcare	313	up+28.4%	up+9.6%	53	up+83.9%	—	No estimate
CONCORDBIO Concord Biotech Ltd	Healthcare	309	up+25.1%	up+18.4%	70	up+10.4%	—	No estimate
SANOFICONR Sanofi Consumer Healthcare India Ltd	Healthcare	263	up+12.4%	up+11.5%	77	up+21.6%	—	No estimate
INDSWFTLAB Ind-Swift Laboratories Ltd	Healthcare	240	up+57.2%	up+25.9%	34	up+327.8%	—	No estimate
VENUSREM Venus Remedies Ltd	Healthcare	219	up+13.3%	up+22.2%	26	up+28.3%	—	No estimate
ADVENZYMES Advanced Enzyme Technologies Ltd	Healthcare	215	up+16.0%	up+12.9%	51	up+13.7%	—	No estimate
RPGLIFE RPG Life Sciences Ltd	Healthcare	212	up+16.3%	up+8.0%	28	down−23.7%	—	No estimate
KOPRAN Kopran Ltd	Healthcare	211	up+79.2%	up+37.2%	4	n/a	—	No estimate
ZOTA Zota Health Care Ltd	Healthcare	199	up+54.5%	up+14.6%	−26	n/a	—	No estimate
SUDEEPPHRM Sudeep Pharma Ltd	Healthcare	197	up+20.7%	up+24.5%	52	up+10.2%	—	No estimate
SAIPARENT Sai Parenterals Ltd	Healthcare	195	n/a	up+9.1%	11	n/a	—	No estimate
SENORES Senores Pharmaceuticals Ltd	Healthcare	192	up+18.7%	up+6.9%	37	up+22.0%	—	No estimate
LINCOLN Lincoln Pharmaceuticals Ltd	Healthcare	191	up+17.4%	up+8.1%	20	up+2.1%	—	No estimate
ANUHPHR Anuh Pharma Ltd	Healthcare	185	down−0.4%	down−4.5%	11	up+40.2%	—	No estimate
WANBURY Wanbury Ltd	Healthcare	183	up+14.3%	up+10.5%	9	down−43.8%	—	No estimate
BAJAJHCARE Bajaj Healthcare Ltd	Healthcare	176	up+18.9%	up+6.0%	14	up+28.1%	—	No estimate
BETA Beta Drugs Ltd	Healthcare	137	up+33.5%	up+9.1%	19	up+60.7%	16.68	No estimate
AMRUTANJAN Amrutanjan Health Care Ltd	Healthcare	135	up+14.9%	up+31.3%	17	up+23.8%	—	No estimate
SIGACHI Sigachi Industries Ltd	Healthcare	130	up+18.1%	up+7.6%	9	down−16.6%	—	No estimate
VALIANTLAB Valiant Laboratories Ltd	Healthcare	117	up+153.9%	up+1.5%	0	n/a	—	No estimate
VIMTALABS Vimta Labs Ltd	Healthcare	112	up+9.8%	up+2.7%	21	up+3.1%	—	No estimate
AHCL Anlon Healthcare Ltd	Healthcare	106	n/a	up+20.6%	17	n/a	—	No estimate
ZIMLAB Zim Laboratories Ltd	Healthcare	105	up+18.9%	up+12.0%	−2	n/a	—	No estimate
JAGSNPHARM Jagsonpal Pharmaceuticals Ltd	Healthcare	96	up+30.2%	up+17.5%	12	down−5.5%	—	No estimate
FABTECH Fabtech Technologies Ltd	Healthcare	92	down−24.2%	up+22.8%	15	down−46.5%	—	No estimate
SAKAR Sakar Healthcare Ltd	Healthcare	87	up+50.7%	up+19.7%	11	up+126.1%	—	No estimate
AMANTA Amanta Healthcare Ltd	Healthcare	83	up+17.3%	up+20.8%	5	up+301.7%	—	No estimate
LAXMIDENTL Laxmi Dental Ltd	Healthcare	80	up+10.4%	up+6.0%	10	up+11.5%	—	No estimate
NURECA Nureca Ltd	Healthcare	59	up+55.1%	up+45.1%	4	up+11.6%	—	No estimate
SHUKRAPHAR Shukra Pharmaceuticals Ltd	Healthcare	44	up+636.7%	up+84.2%	13	up+535.6%	—	No estimate
LYKALABS Lyka Labs Ltd	Healthcare	44	up+20.6%	up+4.5%	1	n/a	—	No estimate
SPARC Sun Pharma Advanced Research Company Ltd	Healthcare	30	up+275.4%	down−24.9%	−24	n/a	—	No estimate
PAR Par Drugs & Chemicals Ltd	Healthcare	27	down−4.3%	down−12.3%	3	down−36.4%	—	No estimate
KREBSBIO Krebs Biochemicals & Industries Ltd	Healthcare	6	up+38.9%	down−17.0%	−5	n/a	—	No estimate

About Q2 FY27 earnings data

How have Indian companies performed in Q2 FY27 so far?

1,325 Indian listed companies have reported Q2 FY27 results; median profit growth is +23.6% on the same quarter last year, and 116 of the 243 companies with analyst estimates beat them. The quarter covers Jul–Sep 2026, ending 30 Sep 2026.

When are Q2 FY27 results announced?

Q2 FY27 covers the Jul–Sep 2026 quarter. Indian listed companies have up to 45 days after a quarter closes to file their results — 60 days for the January–March quarter — so results arrive in a wave over the weeks that follow rather than all at once. A quarter that has only just ended will look sparse and fill in.

How many companies have declared Q2 FY27 results so far?

1,325 of 1,792 companies expected to report this quarter have filed. The rest are still to come; the count updates as filings land.

Why do some Q2 FY27 growth figures show "n/a" instead of a percentage?

Growth is left blank whenever the comparison period was not profitable. A percentage change measured from a loss is arithmetic without meaning — a swing from a ₹10 crore loss to a ₹10 crore profit is not "200% growth", and publishing it as such would flatter the company. The reported figures for both periods are still shown, so the change is there to read directly.

Does the beat/miss verdict cover every company?

No, and the denominator matters. An analyst consensus existed for 243 of the 1,325 companies that reported Q2 FY27 — 18.3%. Beat, missed and in-line describe only those. Every other company is marked "no estimate" rather than being counted as in line, because nobody forecast it. Revenue and profit growth, by contrast, cover every company in the table.

What counts as an in-line result rather than a beat or a miss?

Reported earnings per share within ±2% of the consensus estimate. The band is set there because a tighter one classifies rounding as news, and a wider one swallows surprises that genuinely moved a stock.

Are the figures consolidated or standalone?

Consolidated where a company reports on that basis, standalone otherwise, with all money in ₹ crore. Figures are as filed by the company with the exchanges (NSE/BSE); they are not restated or adjusted.

What does the 8-quarter trend line show?

Quarterly net profit for the last eight quarters, oldest on the left, always ending on the quarter shown in the row. Two years covers both the seasonal shape of the business and its direction. The line breaks where a quarter is missing rather than drawing across the gap, so a break is a real absence of data and not a reported collapse.

How do I find only the companies that beat estimates in Q2 FY27?

Use the Result filter above the table and choose Beat, or sort by EPS surprise to rank every covered company by how far it landed from consensus. Both are reflected in the page URL, so a filtered view can be bookmarked or shared.

Figures are as reported by companies in their quarterly filings to the exchanges (NSE/BSE), in ₹ crore. Consolidated results are shown where a company reports them, otherwise standalone. Year-on-year and quarter-on-quarter growth is omitted where the comparison period was loss-making, since a percentage change from a negative base is not meaningful. Analyst consensus is an estimate, not a forecast of outcome.